Abnormal cellular accumulation of the dicarbonyl metabolite MG (methylglyoxal) occurs on exposure to high glucose concentrations, inflammation, cell aging and senescence. It is associated with increased MG-adduct content of protein and DNA linked to increased DNA strand breaks and mutagenesis, mitochondrial dysfunction and ROS (reactive oxygen species) formation and cell detachment from the extracellular matrix. MG-mediated damage is countered by glutathione-dependent metabolism by Glo1 (glyoxalase 1). It is not known, however, whether Glo1 has stress-responsive up-regulation to counter periods of high MG concentration or dicarbonyl stress. We identified a functional ARE (antioxidant-response element) in the 5 -untranslated region of exon 1 of the mammalian Glo1 gene. Transcription factor Nrf2 (nuclear factor-erythroid 2 p45 subunitrelated factor 2) binds to this ARE, increasing basal and inducible expression of Glo1. Activators of Nrf2 induced increased Glo1 mRNA, protein and activity. Increased expression of Glo1 decreased cellular and extracellular concentrations of MG, MG-derived protein adducts, mutagenesis and cell detachment. Hepatic, brain, heart, kidney and lung Glo1 mRNA and protein were decreased in Nrf2 − / − mice, and urinary excretion of MG protein and nucleotide adducts were increased approximately 2-fold. We conclude that dicarbonyl stress is countered by upregulation of Glo1 in the Nrf2 stress-responsive system, protecting protein and DNA from increased damage and preserving cell function.
INTRODUCTION
Modification of proteins and DNA by the dicarbonyl metabolite MG (methylglyoxal) has emerged as an important endogenous threat to the functional integrity of the proteome and genome. MG is formed by the spontaneous degradation of triose phosphate intermediates and is an unavoidable by-product of anaerobic glycolysis [1] . MG reacts with proteins and DNA forming quantitatively major adducts of endogenous damage, similar to and in some cases exceeding the steadystate levels of adducts produced by oxidative damage. Modification of proteins by MG is directed to arginine residues forming the hydroimidazolone MG-H1 [N δ -(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine] and modification of DNA is directed to deoxyguanosine residues forming the imidazopurinone MGdG {3-(2 -deoxyribosyl)-6,7-dihydro-6,7-dihydroxy-6/7-methylimidazo- [2,3-b] purin-9(8)one} [2, 3] (Figures 1A and  1B) . MG modification of DNA increases DNA strand breaks and frameshift mutation [3, 4] . Protein modification by MG is directed to functional sites where it is associated with metabolic, structural and functional abnormalities: for example, mitochondrial dysfunction with the increased formation of ROS (reactive oxygen species) [5] , cell detachment from the extracellular matrix by decreased integrin binding to MG-modified extracellular matrix proteins and anoikis [6, 7] and induction of accelerated cell senescence [8] . Protein and DNA damage by MG is suppressed by Glo1 (glyoxalase 1) which catalyses the GSH-dependent conversion of MG into S-Dlactoylglutathione. Further metabolism of S-D-lactoylglutathione to D-lactate is catalysed by Glo2 which restores GSH consumed in the Glo1-catalysed reaction [9] ( Figure 1C ). The high reactivity of MG leads to some escape from this detoxification such that in cells 1-5 % of proteins contain MG-H1 residues and up to 1 in 10 5 nucleotides in DNA is a MGdG adduct [2, 3] . Protein and DNA damage increases in periods of increased MG formation and decreased metabolism, such as metabolic stress associated with increased glucose metabolism [6] , decreased GSH in oxidative stress and GSH conjugation with xenobiotic compounds [10] , inflammatory signalling [11] and aging and senescence [12, 13] . In such conditions a stress-responsive . Results in (D and E) are normalized to the percentage of NQO1-ARE positive control, results in (G) are normalized to unstipulated control, and results in (H) are normalized to unstimulated NQO1-ARE vector-transfected control. *P < 0.05, **P < 0.01 and ***P < 0.001 (Student's t test) with respect to empty vector control (D and E) or unstimulated control (G and H).
up-regulation of expression of the GLO1 gene would seem to be advantageous although no such regulatory mechanism is currently known.
Nrf2 (nuclear factor-erythroid 2 p45 subunit-related factor 2) is a member of the CNC (cap 'n' collar) subfamily of bZIP (basic leucine zipper) transcription factors. It is an essential transactivator of genes containing one or more AREs (antioxidant-response elements) in their regulatory regions. Nrf2 co-ordinates increased expression of a battery of ARElinked genes associated with protection against oxidative stress and electrophilic metabolites and decreased expression of lipogenic genes for cell survival and defence [14] . Under basal conditions, Nrf2 is complexed with a Keap1 [Kelch (β-propeller tertiary structure)-like erythroid cell-derived protein with CNC homology-associated protein 1]. Keap1 is a substrate adaptor protein for cullin-3-dependent E2 ubiquitin lipase complex, directing Nrf2 for degradation by the 26S proteasome [15, 16] .
In the present paper, we describe the discovery of a functional ARE in exon 1 of GLO1 which serves to engage Glo1 in the Nrf2 stress-responsive transcriptional system. MG, Glo1 and dicarbonyl stress now emerge as downstream targets by which the Nrf2/Keap1 system exerts its protective functions.
EXPERIMENTAL

Cell culture and treatments
Human hepatoma HepG2 cells and human BJ fibroblasts were cultured in MEM (minimal essential medium) with 10 % FBS (fetal bovine serum) and 2 mM glutamine under an atmosphere of 5 % CO 2 in air, 100 % humidity and 37
• C. Activity of Glo1 was determined by measuring the initial rate of isomerization of the hemithioacetal formed from MG and GSH to S-Dlactoylglutathione followed spectrophotometrically at 240 nm Size of fragment   F1  5 -TTGGTACCTGCCCAACCTCATTTTGGTTA-3  5 -TTGCTAGCTGGCTGAACTGCAGTATCACA-3  ARE-1,2,3  1176  F2  5 -TTGGTACCTCACTTCAGCCCAGGAGT-3  5 -TTGCTAGCTGGCTGAACTGCAGTATCACA-3  ARE-1,2  850  F3  5 -TTGGTACCTGCCTCCTTTATGCGCAAG-3  5 -TTGCTAGCTGGCTGAACTGCAGTATCACA-3  ARE-1  256  F1  5 -TTGGTACCTGCCCAACCTCATTTTGGTTA-3  5 -TTGCTAGCACTGACCCTCTCTGAGCTTCC-3  ARE-3  622   ARE1 mutant  5 -TTGCTAGCTGGCTGAACTGCAGTATCACA-3  ARE-1m,2,3  F1  5 -TTGGTACCTGCCCAACCTCATTTTGGTTA-3  5 -TTGCTAGCTGGCTGAACTGCAGTTATCCAGACGA-3  ARE-1m,2  1176  F3  5 -TTGGTACCTGCCTCCTTTATGCGCAAG-3  5 -TTGCTAGCTGGCTGAACTGCAGTTATCCAGACGA-3  ARE-1m 256 [17] . The MG content of cells and culture medium was determined by stable isotopic dilution analysis liquid chromatography with tandem mass spectrometric detection [6] . The MG-H1 content of cell protein and the MG-H1 and MGdG contents of mouse urine were determined as described in [3, 18] . For cell adhesion assays, BJ fibroblasts were incubated at 37
• C with and without 2 μM SFN (sulforaphane) for 24 h. SFN was non-toxic and did not inhibit cell growth under these conditions (see Supplementary Online Data at http://www.BiochemJ.org/ bj/443/bj4430213add.htm). The culture medium was then removed, incubated with human type IV collagen at 37
• C for 24 h and HMEC-1 (human microvascular endothelial cell 1) attachment was studied as described in [6] .
Frameshift mutation analysis
The pEGFP-CA/T12 vector is a reporter for efficiency of transfection, whereas pEGFP-CA13 vector is a reporter of frameshift mutation [19] . HepG2 cells (2 × 10 5 cells/well) were cultured in 12-well plates for 24 h, the medium was removed, and the cells were washed with serum-free medium and replaced with DNA-Lipofectamine TM complexes in serum-free medium (Lipofectamine TM 2000 reagent, 2 μl; 0.8 μg of pEGFP-CA13 or pEGFP-CA/T12; 2.0 ml of serum-free medium) and incubated for 5 h at 37
• C. The transfection medium was removed and replaced with complete medium (MEM supplemented with 10 % FBS and 2 mM glutamine) and incubated at 37
• C for 48 h. Transfection efficiency was assessed quantitatively by flow cytometry. For HepG2 cells in vitro, the median growth inhibitory concentration of MG was 1.07 + − 0.08 mM (n = 8). HepG2 cells transfected with expression of pEGFP-CA/T12 were incubated with or without 2 μM AITC (allyl isothiocyanate) at 37
• C for 24 h and then with or without 400 μM MG at 37
• C for a further 48 h. Thereafter, cells were washed with PBS and analysed for GFP (green fluorescent protein) expression by flow cytometry.
Real-time PCR
Total RNA was extracted from cultured cells which were treated with SFN using RNeasy Mini Kit (Qiagen). cDNAs were synthesized with oligo(dT) 18 primer and BioScript reverse transcriptase (Bioline). Human GLO1 and ACTB (β-actin reference gene) mRNA were quantified by real-time RT (reverse transcription)-PCR SYBR Green method on ABI 7500 fast real-time PCR system. GLO1 was amplified using the primers 5 -ATGCGACCCAGAGTTACCAC-3 (forward) and 5 -CCAGGCCTTTCATTTTACCA-3 (reverse). The reference gene ACTB was amplified with primers 5 -GGACTTCG-AGCAAGAGATGG-3 (forward) and 5 -AGCACTGTG-TTGGCGTACAG-3 (reverse). For mouse Glo1, the following primers were used: 5 -GATCCAGACCCTAGCACCAA-3 (forward) and 5 -CTTCTGCAGGAGGGTCAGTC-3 (reverse). The reference gene was 18S rRNA with primers purchased from Qiagen. The efficiency of silencing by Nrf2 siRNA (small interfering RNA) was assessed 24 h post-treatment by measurement of decrease in Nrf2 mRNA.
Western blot analysis
Protein extracts (30 μg) were subjected to SDS/PAGE on 10 % polyacrylamide gels. After electrophoresis, the proteins were transferred on to a PVDF membrane and the membrane was blocked with 5 % (w/v) non-fat dried skimmed milk powder in TBST (Tris-buffered saline with Tween 20: 10 mM Tris/HCl, pH 7.5, 150 mM NaCl and 0.05 % Tween 20) and probed with rabbit anti-(human Glo1) antibody [17] . The membrane was incubated at 4
• C overnight. After washing, the membrane was incubated with HRP (horseradish peroxidase)-conjugated secondary antibody for 1 h at room temperature (22
• C). Immunoreactivity was detected using ECL (enhanced chemiluminescence) and intensities of protein bands were quantified by software ImageQuant TL (GE Healthcare). For the reference protein β-actin, the membrane was stripped with stripping buffer (100 mM 2-mercaptoethanol, 2 % SDS and 62.5 mM Tris/HCl, pH 6.8), blocked with 5 % (w/v) non-fat dried skimmed milk powder in TBST and re-probed with anti-β-actin antibody with ECL detection.
Construction of GLO1-ARE and related reporter plasmids
pGL3-NQO1ARE double-stranded DNA oligomer containing the quinone reductase (NQO1) ARE was inserted into pGL3-basic vector by KpnI and NheI double digestion to construct an ARE-positive reporter vector, pGL3-NQO1ARE. The insertion sequence was ggtaccGAGTCGGAAGGTTTAGGCGTCAGTGTCACTGAGTCGTCTTAGcgatcg (the ARE motif is underlined and lower-case letters are the KpnI and NheI restriction sites). The GLO1 promoter pGL3-basic reporter vector construction, a GLO1 gene fragment extending from − 1 (the first base before the start codon) to − 1176 containing three putative AREs, and serial deletion fragments were amplified by PCR from human genomic DNA and cloned into pGL3-basic reporter vector. The primers used to create deletion mutants of human GLO1 promoter fragments are as listed in Table 1 . KpnI and NheI restriction sites were added in PCR primers at the 5 and 3 ends. PCR fragments of the 5 -flanking region in GLO1 gene were amplified using human genomic DNA, and cloned into pJET1.2 Cloning Vector with ClonJET TM PCR cloning kit (Fermentas). The pJET1.2 GLO1 promoter vector was digested with KpnI and NheI and the fragments of the GLO1 promoter region were subcloned into pGL3-basic vector. For the mutant ARE-1, a mutant antisense primer (see Table 1 ) was used to amplify the 5 -flanking region of the GLO1 promoter and subcloned to pGL3-basic reporter vector. All insertion sequences were confirmed by DNA sequence analysis. Four wild-type and two mutant pGL3 reporter vectors for GLO1 promoter were constructed. To assess the conservation of ARE-1 across species, Glo1 exon1 DNA sequence was aligned with the human counterpart by ClustalW2 (EMBL-EBI).
Transfection and luciferase assay of custom vectors
For luciferase assays, 2 × 10 5 HepG2 cells per well were plated into 24-well plates and cultured overnight. The cells were transfected with 0.5 μg of reporter vector and 10 ng of pRL-TK plasmid using Lipofectamine TM 2000 according to manufacturer's protocol. The empty pGL3-basic vector was used as control. After 24 h, 4 μM SFN was added to the cells and vehicle (DMSO) was added to the control. After 24 h, the cells were washed with PBS and a luciferase activity assay was performed immediately or samples stored at − 80
• C until analysis. For the reporter assay, 100 μl of CCLR (Cell Culture Lysis Reagent; Promega) was added to cell extracts which were shaken gently for 30 min. The activity mixture was centrifuged at 12 000 g for 5 min at 4
• C and an aliquot (20 μl) of supernatant used in the reporter assay. The luciferase activity was determined using a Dual Luciferase Reporter Assay System (Promega). The relative luciferase activities were normalized by co-transfection of pRL-TK vector. The cell viability in the transfection assays was 91-96 %.
ChIP (chromatin immunoprecipitation)
ChIP was performed using EZ-ChIP kit (Merck Millipore). HepG2 cells (3 × 10 6 ; seeding density 52 000 cells/cm 2 ) were incubated at 37
• C for 24 h and then treated with 4 μM SFN or vehicle (0.004 % DMSO) for 4 h. Formaldehyde (1 %) was added to the cells and samples were incubated at room temperature for 10 min to cross-link protein-DNA complexes. Excess formaldehyde was quenched by incubation with glycine (62.5 mM) for 5 min at room temperature. Cells were washed twice with PBS containing protease inhibitor cocktail II and cells were collected. Cell pellets were resuspended with 1 ml of SDS lysis buffer and sonicated (15 × 20 s, 25 % output) and centrifuged at 12 000 g for 10 min at 4
• C. An aliquot of supernatant (100 μl) was diluted with 900 μl of ChIP dilution buffer [0.01 % SDS, 1.1 % Triton X-100, 1.2 mM EDTA, 167 mM NaCl and 16.7 mM Tris/HCl (pH 8.1)] and non-specific-binding activity was eliminated by incubation at 37
• C with Protein G-agarose for 1 h. Target DNA fragments were then immunoprecipitated by addition of anti-Nrf2 antibody (H-300, 5 μg; Santa Cruz Biotechnology) incubated overnight at 4
• C. Anti-(RNA polymerase II) antibody and nonimmune IgG (1 μg) were used for controls. Antibody-protein-DNA complex was collected by adding Protein G-agarose. After washing with immune complex wash buffers [low-salt immune complex wash buffer: 0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris/HCl (pH 8.1); high-salt immune complex wash buffer: 0.1 % SDS, 1 % Triton X-100, 2 mM EDTA, 150 mM NaCl and 500 mM Tris/HCl (pH 8.1); and LiCl immune complex wash buffer: 250 mM LiCl, 1 % Igepal, 1 % sodium deoxycholate, 1 mM EDTA and 10 mM Tris/HCl (pH 8.1)], DNA was released by incubation of samples at 65
• C overnight and mRNA and protein were degraded by addition of RNase and proteinase K. Enriched DNA was purified by microspin columns (ChIP DNA Clean&Concentrator Kit, Zymo Research). PCR and real-time PCR were performed with the following primers designed based on the GLO1 promoter target region, forward 5 -GCGTAGTGTGGGTGACTCCT-3 and reverse 5 -TGTGCCCACCTTGGTACTG-3 . DNA extract (4 μl) was used as general PCR template with PCR conditions: 94
• C for 3 min, 40 cycles denaturation at 94
• C for 30 s, annealing at 55
• C for 20 s and extension for 20 s. PCR products were detected on a 4% agarose gel and observed by ethidium bromide under UV illumination. For real-time PCR, DNA extract (2 μl) was used as template with SYBR Green detection. PCR was performed using an ABI 7500 fast real-time PCR system under standard PCR conditions for 50 cycles. The results were analysed using the C T method.
Animal studies
Urine was collected over 24 h under mineral oil from 10-weekold wild-type and Nrf2 − / − mice and MG adducts, MGdG, MG-H1 and creatinine were determined. Other mice were killed, and livers were removed and snap-frozen immediately in liquid nitrogen, stored at − 80
•
− / − mouse and genotyping of progeny have been described elsewhere [20, 26] . Male mice of approximately 10 weeks of age were used throughout the present study. Mice were housed at a temperature range of [19] [20] [21] [22] [23] • C under 12 h light/12 h dark cycles and given free access to food and water. Animals were killed by exposure to a rising concentration of CO 2 followed by cervical dislocation. Livers were removed and snap-frozen immediately in liquid nitrogen, before being stored at − 80
• C. For experiments of treatment with CDDO-Me (methyl 2-cyano-3,12-dioxo-oleana-1,9(11)dien-28-oate), male wild-type and Nrf2 − / − mice (10-12 weeks of age) were treated with a single intraperitoneal injection of 3 mg/kg CDDO-Me or diethyl sulfoxide vehicle control (total volume 100 μl). After 24 h the mice were killed and their livers were removed and snap-frozen in liquid nitrogen, before being stored at − 80
• C until analysis. CDDO-Me was synthesized in-house using a modified version of the method of Sporn et al. [21] .
Statistical analysis
Results are means + − S.D. for parametric data and median (upperlower quartile) for non-parametric data. Significance of difference between mean changes was assessed by Student's t test and median changes by Mann-Whitney U test. All replicates are independent experiments.
RESULTS
A functional ARE in exon 1 of the human GLO1 gene
We analysed the 5 -flanking region of the human GLO1 gene at locus 6p21.2 for the presence of stress-response-related regulatory elements. The human GLO1 gene promoter contains functional insulin-response and metal-response elements [22] . We also found three AREs located at nucleotide sequences (numbered from the start codon) − 10 to − 19, sequence 5 -GTGATACTGCA-3 in exon1 (ARE-1); − 261 to − 252, sequence 5 -ATGAGTTTGCC-3 (ARE-2); and − 1060 to − 1051, sequence 5 -ATGACTAAGCC-3 (ARE-3). We explored the functionality of these AREs by construction of luciferase reporter vectors with whole or segments of this region. Stimulation of the Nrf2 system with SFN, an activator of Nrf2 [23] , showed that ARE-1 alone gave maximal induction of Glo1 transcriptional response and ARE-2 and ARE-3 had little further effect on the inducible transcriptional response ( Figure 1D) . Mutation of the ARE-1 blocked the transcriptional response ( Figure 1E ), indicating that there is inducible expression of GLO1 by activators of Nrf2.
Binding of Nrf2 to the ARE of exon-1 in human GLO1 gene-ChIP assay
Evidence that GLO1-ARE-1 was bound by Nrf2 when activated was sought by a ChIP study with anti-Nrf2 antibody. PCR products overlapping the ARE-1 sequence located at − 9 to − 19 of GLO1 were amplified from immunoprecipitates of HepG2 cells treated with 4 μM SFN. This gave a strong band, whereas corresponding amplification from vehicle-treated cells gave a weak response ( Figure 1F ). Real-time qPCR (quantitative PCR) showed that anti-Nrf2 antibody-enriched DNA fragments in SFN treated cells were increased 2-fold compared with vehicle-treated controls ( Figure 1G ). This confirms that, when activated, Nrf2 binds exon 1 of human GLO1 and thereby provides a stressresponsive inducible increase in Glo1 expression for increased protection against dicarbonyl-mediated protein and DNA damage.
Induction of Glo1 expression by H 2 O 2 -induced oxidative stress
Nrf2 co-ordinates protective gene expression to counter damaging effects of oxidative stress. To assess whether the expression of Glo1 is induced by activation of Nrf2 in the ARE transcriptional response, we studied the effect of H 2 O 2 -induced oxidation stress on the quinone reductase-ARE (NQO1-ARE) transcriptional response as a positive control [24] , and the concomitant GLO1-ARE-1 transcriptional response. HepG2 cells were transfected with NQO1-ARE or GLO1-ARE-1 luciferase reporter vectors, with empty vector and mutant GLO1-ARE-1m as controls, and incubated with 500 μM H 2 O 2 to induce oxidative stress. Owing to the high constitutive cellular activity of H 2 O 2 detoxification in HepG2 cells, a relatively high concentration of H 2 O 2 was required for Nrf2 activation, as found by others [24] ; incubation of cells with 50 μM H 2 O 2 , for example, gave no increase in NQO1-ARE transcriptional response (results not shown). Reporter assay outputs indicated H 2 O 2 -induced oxidation stress activated both the NQO1-ARE and GLO1-ARE-1 transcriptional responses ( Figure 1H ), indicating that expression of Glo1 may be increased in oxidative stress via the Nrf2/ARE transcriptional response.
Induction of Glo1 expression by activators of Nrf2 and protection from dicarbonyl glycation
Activators of Nrf2 are dietary isothiocyanates such as SFN and AITC [25] , but responses induced by them have not hitherto been linked to induction of Glo1 expression and decreased DNA and protein damage caused by MG. Responses of Glo1 expression were studied in human hepatoma HepG2 cells and BJ fibroblasts in vitro. Treatment with 2 μM SFN or AITC increased the activity of Glo1 2-3-fold (Figures 2A and 2B ). There was a related dose-dependent increase in GLO1 mRNA and timecourse changes showing increase to 12 h post-treatment with inducer and decline back to baseline levels thereafter ( Figures 2C  and 2D ). Assessment of Glo1 protein showed a progressive increase over 16 h ( Figure 2E ). The involvement of Nrf2 in induction of Glo1 expression was assessed by siRNA silencing of Nrf2. The efficiency of silencing by transfection with Nrf2 and Nrf2 − / − , n = 6, (J and K) Nrf2 + / + , n = 8, and Nrf2 − / − , n = 9; and means + − S.D. for (E) Nrf2 + / + and Nrf2 − / − , n = 4, (F and G) Nrf2 + / + and Nrf2 − / − , n = 6, (H) Nrf2 + / + , n = 5, and Nrf2 − / − , n = 6, and (I) Nrf2 + / + and Nrf2 − / − , n = 6. *P < 0.05, **P < 0.01 and ***P < 0.001; Student's t test for parametric data (A, B and E-I) and Mann-Whitney U test for non-parametric data (C, D, J and K).
siRNA, as judged by decrease in Nrf2 mRNA normalized to β-actin housekeeping reference mRNA, was 78 + − 9 %. Silencing of Nrf2 expression with siRNA decreased the basal Glo1 mRNA and blocked the increase in Glo1 mRNA in response to SFN ( Figure 2F ). At 24 h post-treatment there was decreased concentration of MG in the cell-culture medium and cells ( Figures 2G and 2H) , and related decrease in cellular protein MG-H1 residue content developed after 48 h ( Figure 2I ). Activation of Nrf2 therefore increased Glo1 expression and activity, decreasing cellular and extracellular concentrations of MG, leading to decreased damage to cellular protein.
Functional effects of induction of GLO1 expression-decreased mutagenesis and loss of cell-matrix interaction
We examined whether increased expression of Glo1 was associated with resistance to cell functional impairment mediated by MG, taking MG-mediated mutagenesis and cell detachment from extracellular matrix as examples.
To assess the effect of inducible expression of Glo1 on MGinduced mutagenesis, we employed a GFP fluorigenic frameshift mutation reporter developed by Kirsch and co-workers [26] and used previously to study frameshift mutations in oxidative stress [19] . Using this we found that MG-induced increased frameshift mutations were prevented by prior induction of Glo1 expression by 2 μM AITC ( Figure 3A) . Increased formation of MG by cells leads to increased release of MG into the extracellular fluid or culture medium [6] . Increased extracellular concentration of MG increases modification of arginine residues in integrinbinding sites of extracellular matrix proteins and decreases cell-extracellular matrix interactions leading to cell detachment and anoikis, as found for vascular endothelial cells [6] , renal mesangial cells [7] and peripheral neurons [27] . Induction of Glo1 expression in BJ fibroblasts decreased extracellular MG (see above). Conditioning of type IV collagen in this MG-depleted medium preserved the binding of endothelial cells beyond that found with control culture medium ( Figure 3B ). These studies show that increased expression of Glo1 by activation of the Nrf2 system counters functional impairment of DNA and extracellular matrix proteins.
Regulation of Glo1 expression by Nrf2 and protection against protein and nucleotide damage in vivo
To assess whether this protective mechanism of Nrf2 and Glo1 operates in vivo, we measured the urinary efflux of nucleoside Figure 4 Transcriptional control of GLO1 by Nrf2 for enhanced protection of the proteins and DNA from dicarbonyl glycation damage (A) Schematic summary, and (B) conservation of ARE-1 in exon 1 of GLO1. *Consensus ARE is a weighted consensus ARE derived from comparisons of human, mouse and rat ARE-linked genes [58] . Grey filled entries indicate disparity with human Glo1-ARE of exon 1.
adduct MGdG and arginine-derived MG-H1 free adduct in wild-type and mutant Nrf2 − / − mice. There was decreased expression of Glo1 in mutant Nrf2 − / − mice, as was evident from decreased Glo1 mRNA ( − 18 %, P < 0.001) and protein ( − 39 %, P < 0.01) in the liver (Figures 3C and 3D ). There were similar decreases in Glo1 protein in the brain, heart and kidney ( − 27 %, − 30 % and − 26 % respectively; P < 0.001), and a smaller decrease in Glo1 protein in the lung ( − 8 %, P < 0.01) (Figures 3E-3H ). Wild-type (Nrf2 + / + ) mice treated with the Nrf2 activator CDDO-Me (3 mg/kg) had a small significant increase in Glo1 protein content of liver in wild-type mice ( + 6 %, P < 0.05), but not in Nrf2 − / − mice ( Figure 3I ). We also assessed markers of nucleotide and protein damage in wild-type (Nrf2 + / + ) control mice and mutant Nrf2 − / − mice. There was an approximately 2-fold increase in urinary excretions of MGdG and MG-H1 in Nrf2
− / − mice with respect to wild-type (Nrf2 + / + ) controls, suggesting that the Nrf2 system does indeed serve to protect against MG-mediated nucleotide and protein damage in vivo ( Figures 3J and 3K ).
DISCUSSION
The Glo system is a detoxification system for endogenous acyclic dicarbonyl metabolites such as MG and glyoxal. It has an established role in the enzymatic defence against protein and nucleotide glycation by dicarbonyls [28] , but transcriptional control of Glo1 by a stress-responsive mechanism has not hitherto been disclosed. Induction of Glo1 expression has been found in cells exposed to metabolic and inflammatory stress in vitro and in vivo: glomerular cells challenged by increased MG formation in hyperglycaemia associated with diabetes [29] , mesothelial cells challenged by MG and high glucose concentrations of clinical dialysis fluids [30] and inflammatory stress induced by amyloidosis of AD (Alzheimer's disease) [31] and overexpression of α-synuclein in an experimental model of Parkinson's disease [32] . In these cases of increased cell dysfunction and damage and physiological morbidity, Glo1 induction was insufficient to prevent increased protein damage by MG. The mechanism of induction was unknown, but can now be linked to the endogenous Nrf2-mediated anti-stress gene response known to be activated in these conditions [33] [34] [35] [36] . Studies with Glo1-overexpressing transgenic animals have indicated that increased expression of Glo1 has beneficial effects, such as maintenance of vascular cell responses, prevention of myocardial cell death when oxygenated after ischaemia and delay of aging and senescence [13, 37, 38] .
In the present study, we found that Glo1 mRNA, protein and activity were increased in HepG2 cells and BJ fibroblasts in vitro on treatment with activators of Nrf2, SFN and AITC, and that this was mediated by interaction of Nrf2 with an ARE in exon 1 of the GLO1 gene. In BJ fibroblasts, the GLO1 mRNA was increased by treatment with SFN for up to 12 h and thereafter declined back to control levels by 24 h. There was concomitant increase in Glo1 protein up to 12 h and little decline thereafter at 16 h. These temporal changes are likely to be due to inactivation of SFN by hydrolysis in the initial 8-12 h and induction of GLO1 mRNA and protein where the latter is longer lived than the former. Consistent with this was the hydrolysis and inactivation of the related dietary isothiocyanate phenethyl isothiocyanate with a half-life of approximately 2.4 h under physiological conditions [39] and half-lives of GLO1 mRNA and protein of 15 h (HepG2 cells) and 63 h (MCF7 cells) respectively [40, 41] .
The anti-stress gene response mediated by Nrf2 co-ordinates increased expression of protective genes and decreased expression of lipogenic genes for survival and defence in stressful conditions [14] . Critical in achieving this is probably protection of proteins and DNA from endogenous damaging modifications. It is in keeping with this function that activation of Nrf2 increases the expression of Glo1 and protects against dicarbonyl stress. Dicarbonyl stress is an imbalance between formation of dicarbonyl metabolites and enzymatic defences against them in favour of the former leading to increased cell damage. It has emerged as an important endogenous threat to the functional integrity of the proteome and genome [3, 18] . Enhanced protection against MG-mediated damage by induction of Glo1 expression is a novel and vital mechanism by which the Nrf2 antistress gene response is a guardian of physiological systems ( Figure 4A ). Increased cellular concentrations of MG were found in experimental models of oxidative stress in vitro [10] . We found that H 2 O 2 -induced oxidative stress activated Nrf2 and increased the NQO1-ARE transcriptional response, a marker of the protective Nrf2/ARE stress-response system [24] . There was a concomitant increase in the GLO1-ARE transcriptional response. This further supports the role of increased expression of Glo1 via the Nrf2 system as a protective stress response which may be activated in oxidative stress.
Proteins susceptible to dicarbonyl modification with related functional impairment, the dicarbonyl proteome, have yet to be fully characterized, but they include mitochondrial proteins, extracellular matrix proteins, lipoproteins and transcriptional factors [42] . Increased functional impairment is linked to structural impairment of proteins and signalling dysfunction in multiple metabolic pathways [43] , indicating its importance and more general significance in physiological systems.
Transcriptional regulation of Glo1 by Nrf2 may provide a new strategy in enhancing Glo1 expression for prevention of cell dysfunction and death in aging and disease. It also explains previous independent findings of increased Glo1 expression in an experimental background of Nrf2 activation where the origin and mechanism of this increase was not explored. Induction of Glo1 expression was found in murine intestinal tissue and brain cortex by treatment of mice with butylated hydroxyanisole and the flavonol fisetin respectively; both compounds are activators of Nrf2 [44, 45] . We found a weak induction of murine hepatic Glo1 by the potent Nrf2 activator CDDO-Me in wild-type but not in Nrf2 − / − mice. To decrease the cellular and extracellular concentrations of MG, induction of Glo1 expression as a pharmacological strategy for therapeutic intervention has a significant advantage over other approaches, such as chemical scavengers of MG (e.g. aminoguanidine [46] ), as only a small amount of Glo1 inducer is required to enhance endogenous catalytic removal of MG and the high chemical reactivity necessary for effective MG-scavenging agents (and related risk of adverse effects) is not required.
Likely benefits of pharmacological induction of Glo1 are evident from studies of overexpression of Glo1 models of disease mechanisms. Experimental evidence is currently best established for vascular complications of diabetes. In cell culture systems incubated under high glucose concentrations to model diabetesassociated hyperglycaemia, overexpression of Glo1 prevented increased formation of ROS, inflammatory mediators S100A8, S100A12 and high-mobility box-1 protein, increased expression of the RAGE (receptor for advanced glycation end-products) [47] , and corrected angiogenesis deficit of endothelial cells [48] and dysfunction of endothelial progenitor cells [49] . Employing Glo1 transgenic rats, overexpression of Glo1 in vivo decreased the AGE (advanced glycation end-product) and oxidative damage marker contents of tissues and prevented impairment of endotheliumdependent vasorelaxation of the streptozotocin-induced diabetic rats [37, 50] . Recent research has also indicated that Glo1 may protect against formation of atherogenic LDL (low-density lipoprotein) [51] . Glo1 inducers may therefore find use in treatment and prevention of early-stage vascular complications of diabetes: nephropathy, retinopathy, peripheral neuropathy and CVD (cardiovascular disease) [52] . Glo1 has a regulatory insulin-response element that also regulates expression [22] ; treatment with insulin was not sufficient to prevent increased MG and MG-modified protein damage in experimental and clinical diabetes [18, [53] [54] [55] . A further application for Glo1 inducers is prevention of renal and myocardial reperfusion injury. Glo1 transgenic rats were resistant to renal reperfusion injury, showing decreased AGE accumulation, oxidative stress and renal tubular cell apoptosis [38] . Similar evidence is currently unavailable for myocardial reperfusion injury after acute myocardial infarction, but MG has been found to induce increases cardiomyocyte ischaemia/reperfusion in vitro [56] . Glo1 inducers are also likely to find benefit in renal failure, countering the increased exposure to MG and thereby countering the potential for increased formation of atherogenic MG-modified LDL [51, 57] . There is evidence of a progressive decline in Glo1 expression and activity in aging (reviewed in [9] ), and Glo1 inducers may counter this. Dietary bioactive inducers of Glo1 may provide resistance to development of aging-related disorders or healthy aging.
Investigation of species conservation of ARE-1 in the GLO1 gene showed high sequence identity in primates and high sequence identity and similarity in mouse, rat, pig and cow, and with the overall consensus human ARE motif for basal and inducible expression [58] (Figure 4B ). This regulation is conserved in mammalian cells and probably extends to other species with a functional Nrf2 system and orthologues, such as SKN-1 of nematodes; increased Glo1 expression was found in experimental oxidative stress in the parasitic nematode Onchocerca volvulus [59] . This further underlines the importance of regulatory increase of cell defences against dicarbonyl stress through the Nrf2-AREGlo1 interaction revealed in the present study. 
